Vara is dedicated to making data-driven breast cancer screening more accessible to everyone. They aim to detect every deadly breast cancer early to ensure better outcomes worldwide. Combining advanced AI technology with the expertise of leading physicians, Vara provides reliable breast cancer screening with measurable impact backed by clinical evidence.

Vara develops a platform that supports the entire breast cancer screening pathway—helping from appointment booking, radiology operations, scan readings, lab results, communication of results, to treatment referrals. The platform has been evaluated in the largest prospective study involving nearly half a million women and screening units in Germany, demonstrating significant improvements in cancer detection, workload reduction, and reduced unnecessary recalls.

The company is a spin-off from Merantix Venture Studio in 2018 and has secured major funding rounds including a €6.5M Series A led by OMERS Ventures. Vara is certified as a CE Class IIb medical device and compliant with stringent European Medical Device Regulation. Their AI-driven solutions are deployed internationally including Germany, Mexico, Greece, India, and Egypt.

Vara offers a flexible work environment, competitive salary, and opportunities for career development. Their hiring process values finding the right candidate and includes multiple stages such as application, introduction to the hiring manager, site visits at their AI Campus, and thorough assessment to ensure fit.

They promote a culture of ownership, diversity, continuous learning, and impact-driven work with a supportive and respectful team environment.